Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
mvm.com

See what CB Insights has to offer

Investments

77

Portfolio Exits

21

Funds

1

About MVM Partners

MVM Partners is a venture capital firm.

MVM Partners Headquarter Location

6 Henrietta Street

London, England, WC2E 8PU,

United Kingdom

+44(0) 20 7557 7500

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

MVM Partners Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

MVM Partners Rank

Latest MVM Partners News

Georgia Bio Names 2022 Golden Helix Award Winners

Apr 11, 2022

Clearside Biomedical’s Rafael Andino and The Georgia Institute of Technology’s Krishnendu Roy to be Honored with Top Award April 11, 2022 11:21 AM Eastern Daylight Time ATLANTA--( BUSINESS WIRE )--Georgia Bio, the state’s life science trade association, will celebrate its annual Golden Helix Awards on Thursday, May 5th. Georgia Bio is pleased to announce the winners of the 2022 Golden Helix Awards and be returning to an in-person celebration. Clearside Biomedical’s Rafael V. Andino and The Georgia Institute of Technology’s Krishnendu Roy are the recipients of the 2022 Industry Growth Awards for their impact on the life sciences industry in the state. The Industry Growth Awards are the highest honors bestowed each year by Georgia Bio. The Golden Helix Awards celebrate the contributions and achievements of Georgia legislative, academic, corporate, and other organizational leaders working to advance the growth of the life sciences industry and foster strategic partnerships that can create a healthier world. The event is expected to draw 300 of the state’s life sciences industry leaders. “We are thrilled to have our annual awards dinner return to being an in-person celebration of the individuals and companies who are making waves in the life sciences industry,” said Maria Thacker Goethe, CEO, Georgia Bio and the Center for Global Health Innovation (CGHI), “Our community strives to improve patients’ lives, support workforce development, grow Georgia’s economy, and be a driving force for good in the world. The Golden Helix Awards highlights those lasting contributions made by many in the life sciences sector in Georgia.” Now in its 24th year, the Golden Helix Award winners showcase the best in innovation and leadership in Georgia’s community. Georgia Bio presents awards to individuals and companies in eight categories: Industry Growth; Deals of the Year; Community; Innovation; Emerging Leader; Biotech Teacher of the Year; Legislator of the Year; and the Metro Atlanta Chamber sponsored Phoenix Award. Winners are some of Georgia’s hardest working innovators and entrepreneurs producing advanced medicines, diagnostics and technologies to improve medical care. Companies being honored with the distinguished Deal of the Year award include: Antios Therapeutics for their successful fundraising efforts, which included closing on a Series B financing round totaling $107 million dollars; Axion Biosystems for their sale to Summa Capital; Guide Therapeutics for their sale to Beam Therapeutics; Danimer Scientific for their $700 million dollar expansion of a 2,000,000-square-foot facility in Bainbridge, Georgia; MedShape, Inc. for their sale to DJO; Intuitive Surgical’s commitment to creating 1,200 new jobs that will have an average salary of over $130,000 in Gwinnett County; Kennesaw State University for earning a three-year, $809,000 grant from the National Institutes of Health (NIH) to strengthen the University’s research and diversity infrastructures in the biomedical fields; Sharecare for going public through a merger with Falcon Capital Acquisition Corp.; Strados Labs for raising $4.5M in Pre-series A Funding; and VERO Biotech for receiving $100 million in a Series E financing round led by MVM Partners (MVM). “The Metro Atlanta Chamber is honored to present the Phoenix Award this year to two titans of economic development in Georgia for their partnership in creating the Delta Innovation Hub at the University of Georgia,” said David Hartnett, Chief Economic Development Officer at the Metro Atlanta Chamber, and member of the Georgia Bio Awards Committee. “Their collaboration will invigorate Georgia’s innovation ecosystem for years to come and symbolizes what the spirit of the Golden Helix Awards and Phoenix Awards is all about.” AWARD WINNERS Georgia Bio Industry Growth Awards: Presented to two people who have made an extraordinary contribution to the growth of the life sciences industry in Georgia. Rafael V. Andino, Clearside Biomedical, Inc. Krishnendu Roy, Georgia Institute of Technology Phoenix Award: The Phoenix award represents the iconic "rising from the ashes" of the Phoenix, a symbol of strength, tenacity and leadership and is presented to celebrate the best Industry and Academic collaborations. The two Georgia honorees will have forged academic and industry relationships that will drive translation and lead to new treatments and cures. This award is sponsored by the Metro Atlanta Chamber . Delta Air Lines Foundation UGA Innovation District Deals of the Year Awards: Presented to one or more companies or institutions for the most significant financial or commercial transactions closed from January 1, 2021-December 31, 2021, based on the importance of the transaction to Georgia’s life sciences industry. Acquisitions Beam Therapeutics acquisition of Guide Therapeutics DJO acquisition of MedShape, Inc. Economic Development Kennesaw State University Community Awards: Presented to a small number of individuals, companies or institutions whose contributions to Georgia’s life sciences community are worthy of special recognition. Ian Biggs, University of Georgia Innovation Gateway Angelita Howard, EdD, MBA-PM, MA, Morehouse School of Medicine Wilbur Lam, MD, PhD, Emory University & Georgia Institute of Technology Dorothy Leone-Glasser, RN, HHC, Advocates for Responsible Care Marine Extension & Georgia Sea Grant, University of Georgia Grace Powers, MS, MBA, RAC, Powers Regulatory Consulting Ryan White Program, Augusta University Innovation Awards: Presented to the department, institution, company or individuals who are forging new ground by thinking outside traditional paradigms to create some unique technology. GENOSYL, VERO Biotech Emerging Leader of the Year Awards: Presented to young individuals who have made a significant impact on the life sciences industry through their studies or employment. Aaron Enten, PhD, MBA, Insight Optics Teacher of the Year Award: Presented to a Georgia biotechnology high school teacher who exhibits excellence in STEM teaching and support for the biotechnology pathway. Cynthia Greer, North Hall High School Legislators of the Year Award: Presented to state legislators for their support of the life sciences industry in Georgia. The Honorable Chuck Hufstetler, Georgia State Senate The Honorable Shaw Blackmon, Georgia House of Representatives For a list of past Georgia Bio Industry Growth Award recipients, click here . ABOUT GEORGIA BIO (GaBio) Georgia Bio is a division of the Center for Global Health Innovation (CGHI), a 501(c)(3) organization that was launched in January 2020 to bring together diverse Global Health, Health Technology and Life Sciences entities to collaborate, innovate and activate solutions to enhance human health outcomes around the world. Visit CGHI at cghi.org . Credentialed members of the news media are invited to attend as guests. Please register with Georgia Bio. Contacts

MVM Partners Investments

77 Investments

MVM Partners has made 77 investments. Their latest investment was in Nalu Medical as part of their Series D on February 2, 2022.

CBI Logo

MVM Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/18/2022

Series D

Nalu Medical

$104M

Yes

8

1/7/2022

Series E

VitalConnect

$39M

No

10

9/8/2021

Series D

InBrace

$102M

Yes

15

3/10/2021

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

10

11/18/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/18/2022

1/7/2022

9/8/2021

3/10/2021

11/18/2020

Round

Series D

Series E

Series D

Unattributed VC

Series B

Company

Nalu Medical

VitalConnect

InBrace

Subscribe to see more

Subscribe to see more

Amount

$104M

$39M

$102M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

8

10

15

10

10

MVM Partners Portfolio Exits

21 Portfolio Exits

MVM Partners has 21 portfolio exits. Their latest portfolio exit was Patient Connect on December 22, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/22/2021

Acquired

$99M

1

11/4/2021

IPO - II

$99M

Public

6

1/5/2021

Acquired

$99M

17

8/19/2020

Acq - P2P

Subscribe to see more

$99M

Subscribe to see more

10

12/31/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/22/2021

11/4/2021

1/5/2021

8/19/2020

12/31/2019

Exit

Acquired

IPO - II

Acquired

Acq - P2P

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

1

6

17

10

10

MVM Partners Acquisitions

1 Acquisition

MVM Partners acquired 1 company. Their latest acquisition was AmbioPharm on November 20, 2014.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

11/20/2014

Private Equity

$99M

Acq - Fin

2

Date

11/20/2014

Investment Stage

Private Equity

Companies

Valuation

$99M

Total Funding

Note

Acq - Fin

Sources

2

MVM Partners Fund History

1 Fund History

MVM Partners has 1 fund, including MVM IV.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/3/2016

MVM IV

$233M

3

Closing Date

5/3/2016

Fund

MVM IV

Fund Type

Status

Amount

$233M

Sources

3

MVM Partners Team

1 Team Member

MVM Partners has 1 team member, including current Managing Partner, Stephen Reeders.

Name

Work History

Title

Status

Stephen Reeders

Managing Partner

Current

Name

Stephen Reeders

Work History

Title

Managing Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.